Park Square Financial Group’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-43
Closed -$685 247
2025
Q3
$685 Buy
+43
New +$708 ﹤0.01% 233

Other funds holding BTAL

Park Square Financial Group's BTAL Position: Q4 2025 in Review

Park Square Financial Group sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2025, closing a stake of 43 shares — an estimated $685 sold.

Park Square Financial Group first reported a position in BTAL in Q3 2025 and held it in 1 quarter. The position peaked at $685 in Q3 2025. 81 funds tracked by Wall St. Rank hold BTAL as of Q4 2025.

  • Park Square Financial Group reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2025 after selling out during the quarter.
  • Park Square Financial Group sold 43 AGF US Market Neutral Anti-Beta Fund shares in Q4 2025, an estimated $685.
  • Park Square Financial Group first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2025 and held it in 1 quarter.
  • Park Square Financial Group's AGF US Market Neutral Anti-Beta Fund position peaked at $685 in Q3 2025.
  • 81 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2025.

Based on Park Square Financial Group's 13F filing for Q4 2025, filed 5 Feb 2026.